Enecadin

Generic Name: Enecadin

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₁H_₂₈FN_₃O

CAS Number: 259525-01-4

Unique Ingredient Identifier: VR034VW8OG

Background: Enecadin has been investigated for the treatment of Stroke.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Tolerability of Enecadin (INN) in Acute Ischemic Stroke Trial - TEST

Phase 2

Terminated

Conditions: Stroke

Interventions: Drug: Placebo
Drug: Enecadin

First Posted Date: 2006-05-31

Last Posted Date: 2008-05-22

Lead Sponsor: PAION Deutschland GmbH

Target Recruit Count: 24

Registration Number: NCT00331721

Locations: 🇦🇹
Investigational Site 1, Linz, Austria
🇦🇹
Investigational Site 2, Linz, Austria
🇩🇪
Investigational Site, Wiesbaden, Germany

and more 1 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy